BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual General […]
UPDATED – SYLA Technologies to Participate in the NASDAQ JAPAN IR EVENT
TOKYO, May 17, 2024 (GLOBE NEWSWIRE) — SYLA Technologies Co., Ltd. (Nasdaq: SYT) (“SYLA” or “the Company”), operator of the […]
Manitoba On-Farm Installation and Closing of Private Placement First Tranche
WATERLOO, Ontario, May 17, 2024 (GLOBE NEWSWIRE) — FuelPositive Corporation, a leading Green Ammonia Company (TSX.V: NHHH) (OTCQB: NHHHF) (the […]
TSX News -
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
MONTREAL, May 17, 2024 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (the “Company” or “IntelGenx”) (OCTQB: IGXT; TSX: IGX), a leading drug […]
HUTCHMED announces retirement of Chairman, appointment of new Chairman and change of members of board committees
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED” or the […]
Willis Lease Finance Corporation Declares First Ever Cash Dividend
COCONUT CREEK, Fla., May 17, 2024 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC”), the leading lessor of […]
Assertio to Participate in Benchmark Healthcare Conference on May 21-22
LAKE FOREST, Ill., May 17, 2024 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical […]
Varonis to Present at Upcoming Investor Conferences
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), a leader in data security, announced its […]
Stellantis Announces Changes in Leadership Team
Stellantis Announces Changes in Leadership Team AMSTERDAM, May 17, 2024 – Stellantis today announced the following organizational changes, effective June […]
Phio Pharmaceuticals Secures New Investor
MARLBOROUGH, Mass., May 17, 2024 (GLOBE NEWSWIRE) — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary […]
